Medicament for treating anaphylactoid purpura

A technology for allergic purpura and drugs, applied in allergic diseases, drug combinations, pharmaceutical formulas, etc., can solve problems such as unsatisfactory curative effect, toxic and side effects, and drug dependence of patients, and achieve good clinical effects, no toxic and side effects, The effect of convenience

Inactive Publication Date: 2011-09-28
如东县马塘镇企业服务中心(如东县马塘镇统计站)
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there are many medicines for the treatment of this disease at present, most of them are western medicines. Although these western medicines have certain curative effects, their toxic and side effects are also more serious, and patients are prone to drug dependence

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0019] Example 1

[0020] The drug for the treatment of allergic purpura of this Faming is made from the following raw materials: 4 grams of Polygonatum, 3 grams of Tinglizi, 5 grams of Commelina chinensis, 7 grams of Kusatsuma, 6 grams of pomegranate peel, and 15 grams of Comfrey , 3 grams of safflower, 12 grams of ginseng, 11 grams of rehmannia, 7 grams of angelica, 11 grams of red peony, 11 grams of double flower, 9 grams of salvia, 9 grams of Puhuang, 3 grams of rush, 13 grams of astragalus, 7 grams of wind, 10 grams of medlar, 10 grams of Banlangen, 7 grams of Atractylodes macrocephala, 5 grams of gardenia, 12 grams of fried scutellaria, and 11 grams of thistle.

[0021] Preparation method: water decoction method, decoct in water twice, combine the two filtrates, and divide into two parts.

[0022] Usage and dosage: take orally, once in the morning and evening, one pair per day, 30 days as a course of treatment.

Example Embodiment

[0023] Example 2

[0024] The medicine for the treatment of allergic purpura of the present invention is made of the following raw materials: Polygonatum 3 grams, Tinglizi 2 grams, Commelina 4 grams, Scutellaria 6 grams, pomegranate peel 5 grams, Comfrey 13 grams, 2 grams of safflower, 10 grams of ginseng, 10 grams of rehmannia, 6 grams of angelica, 10 grams of red peony root, 10 grams of double flower, 8 grams of salvia miltiorrhiza, 8 grams of Puhuang, 2 grams of rush grass, 12 grams of astragalus, 6 grams of windproof, wolfberry 9 grams of Radix Isatidis, 9 grams of Banlangen, 6 grams of Atractylodes macrocephala, 4 grams of Gardenia, 10 grams of fried scutellaria, and 10 grams of thistle.

[0025] All the other are identical with embodiment 1.

Example Embodiment

[0026] Example 3

[0027] The medicine for the treatment of allergic purpura of the present invention is made of the following raw materials: Polygonatum 5 grams, Tinglizi 4 grams, Commelina 6 grams, Scutellaria 8 grams, pomegranate peel 7 grams, Comfrey 17 grams, 4 grams of safflower, 14 grams of ginseng, 12 grams of rehmannia, 8 grams of angelica, 12 grams of red peony root, 12 grams of double flower, 10 grams of salvia miltiorrhiza, 10 grams of Puhuang, 4 grams of rush grass, 14 grams of astragalus, 8 grams of windproof, wolfberry 11 grams of Radix Isatidis, 11 grams of Radix Isatidis, 8 grams of Atractylodes Rhizome, 6 grams of Gardenia, 14 grams of fried Scutellaria baicalensis, and 12 grams of thistle.

[0028] All the other are identical with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicament for treating anaphylactoid purpura, which is prepared from the following raw materials in parts by weight: 3 to 5 parts of solomonseal, 2 to 4 parts of pepperweed seed, 4 to 6 parts of dayflower herb, 6 to 8 parts of prunella vulgaris, 5 to 7 parts of pomegranate rind, 13 to 17 parts of lithospermum, 2 to 4 parts of safflower, 10 to 14 parts of figwort root, 10 to 12 parts of rehmannia glutinosa, 6 to 8 parts of angelica, 10 to 12 parts of red peony root, 10 to 12 parts of honeysuckle, 8 to 10 parts of danshen root, 8 to 10 parts of cattail pollen, 2 to 4 parts of rush pith, 12 to 14 parts of milkvetch root, 6 to 8 parts of divaricate saposhnikovia root, 9 to 11 parts of wolfberry fruit, 9 to 11 parts of isatis root, 6 to 8 parts of atractylodes, 4 to 6 parts of gardenia, 10 to 14 parts of stir-fried baikal skullcap root and 10 to 12 parts of field thistle herb. The medicament disclosed by the invention has the advantages of fine curative effect, rapid effect, no toxic or side effect, low manufacturing cost, convenience for oral administration, treatment for both manifestation and root cause of disease and no recurrence, and has fine clinical effect on a patient after 3 to 5 courses of treatment of oral administration.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a medicine for treating allergic purpura. Background technique [0002] Henoch-Schonlein purpura is a relatively common medical disease. The clinical symptoms are subcutaneous plaques and small spotting of the lower extremities. The spotting is purple and does not fade after pressing. Symptoms and laboratory tests showed no abnormalities. Modern medicine believes that the disease may be caused by various sensitizing factors acting on the human body through an allergic reaction. Although there are many medicines for the treatment of this disease at present, most of them are western medicines. Although these western medicines have certain curative effects, their toxic and side effects are also more serious, and patients are prone to drug dependence; Lack of the method for preventing recurrence; In addition, existing Western medicines generally have the problems that t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8969A61P37/08A61P7/04
Inventor 刘艳菊
Owner 如东县马塘镇企业服务中心(如东县马塘镇统计站)
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products